Drägerwerk AG & Co. KGaA (DGWPF)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist Drägerwerk AG & Co. KGaA (DGWPF) ein Healthcare-Unternehmen mit einer Bewertung von 0. Bewertet mit 47/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 15. März 2026Drägerwerk AG & Co. KGaA (DGWPF) Gesundheitswesen & Pipeline-Uebersicht
Drägerwerk AG & Co. KGaA, founded in 1889, is a global medical and safety technology provider specializing in acute point-of-care solutions and personal protection equipment. With a presence in Europe, the Americas, Africa, Asia, and Australia, the company serves diverse sectors, including healthcare, industry, mining, and public safety.
Investmentthese
Drägerwerk AG & Co. KGaA presents a compelling investment case based on its established market position, diverse product portfolio, and global reach. With a P/E ratio of 13.39 and a dividend yield of 2.35%, the company offers a blend of value and income. A gross margin of 45.4% indicates solid profitability. Growth catalysts include expansion in emerging markets and increased demand for safety equipment. Potential risks include regulatory changes and competition from established players. The company's beta of 0.69 suggests lower volatility compared to the broader market. Investors should monitor the company's ability to maintain its market share and adapt to evolving industry standards.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $1.44 billion reflects its significant presence in the medical and safety technology market.
- P/E ratio of 13.39 suggests a potentially undervalued stock compared to its earnings.
- Gross margin of 45.4% indicates efficient cost management and strong pricing power.
- Dividend yield of 2.35% provides a steady income stream for investors.
- Beta of 0.69 indicates lower volatility compared to the overall market, making it a potentially stable investment.
Wettbewerber & Vergleichsunternehmen
Staerken
- Strong brand reputation in medical and safety technology.
- Diversified product portfolio catering to multiple industries.
- Global presence with operations in Europe, the Americas, Africa, Asia, and Australia.
- Extensive experience in navigating regulatory requirements.
Schwaechen
- Dependence on specific industries, such as healthcare and mining.
- Exposure to currency exchange rate fluctuations.
- Potential for product liability claims.
- Limited brand recognition in some emerging markets.
Katalysatoren
- Ongoing: Increasing demand for medical devices and safety equipment due to global health concerns and stricter regulations.
- Ongoing: Expansion in emerging markets with growing healthcare and industrial sectors.
- Upcoming: Potential new product launches in digital health and remote patient monitoring.
- Ongoing: Strategic partnerships and acquisitions to expand product portfolio and market reach.
- Ongoing: Government investments in healthcare infrastructure and safety initiatives.
Risiken
- Potential: Intense competition from established players in the medical and safety technology markets.
- Potential: Changes in regulatory requirements and healthcare policies.
- Potential: Economic downturns affecting demand for products and services.
- Potential: Disruptions in supply chains and manufacturing processes.
- Ongoing: Currency exchange rate fluctuations affecting international sales and profitability.
Wachstumschancen
- Expansion in Emerging Markets: Drägerwerk can capitalize on the growing healthcare and safety markets in emerging economies, particularly in Asia and Latin America. These regions are experiencing increased healthcare spending and stricter safety regulations, driving demand for Drägerwerk's products and services. A targeted market entry strategy, including partnerships and localized product offerings, could significantly boost revenue. The emerging markets healthcare sector is projected to grow at a CAGR of 8-10% over the next five years.
- Product Innovation in Digital Health: Investing in digital health solutions, such as remote patient monitoring and telehealth platforms, can drive growth. Integrating these technologies with existing medical devices can enhance patient care and improve efficiency. The digital health market is rapidly expanding, with a projected market size of hundreds of billions of dollars by 2028. Drägerwerk's expertise in medical technology positions it well to capture a significant share of this market.
- Increased Demand for Personal Protective Equipment (PPE): The ongoing emphasis on workplace safety and hygiene, accelerated by recent global health crises, is driving demand for PPE. Drägerwerk can expand its PPE product line and distribution channels to capitalize on this trend. The global PPE market is expected to continue growing at a steady pace, presenting a significant opportunity for Drägerwerk.
- Strategic Acquisitions: Pursuing strategic acquisitions of smaller companies with complementary technologies or market access can accelerate growth. Acquiring companies specializing in niche areas, such as respiratory care or gas detection, can broaden Drägerwerk's product portfolio and strengthen its competitive position. Successful acquisitions can lead to synergies and increased market share.
- Service and Training Expansion: Expanding service and training offerings can generate recurring revenue and enhance customer loyalty. Providing comprehensive training programs for healthcare professionals and industrial workers on the proper use and maintenance of Drägerwerk's products can differentiate the company from competitors. Service contracts and training programs can provide a stable revenue stream and strengthen customer relationships.
Chancen
- Expansion in emerging markets with growing healthcare and safety needs.
- Development of innovative digital health solutions.
- Increased demand for personal protective equipment (PPE).
- Strategic acquisitions of companies with complementary technologies.
Risiken
- Intense competition from established players in the medical and safety technology markets.
- Changes in regulatory requirements and healthcare policies.
- Economic downturns affecting demand for products and services.
- Disruptions in supply chains and manufacturing processes.
Wettbewerbsvorteile
- Established Brand Reputation: Drägerwerk has a long-standing reputation for quality and reliability in the medical and safety technology markets.
- Extensive Product Portfolio: The company offers a diverse range of products and services, catering to various customer needs and industries.
- Global Presence: Drägerwerk operates in multiple regions, providing access to diverse markets and reducing reliance on any single region.
- Regulatory Expertise: The company has extensive experience navigating regulatory requirements in the medical and safety technology sectors.
Ueber DGWPF
Founded in Lübeck, Germany, in 1889, Drägerwerk AG & Co. KGaA has evolved into a global leader in medical and safety technology. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. Its medical product portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Drägerwerk also provides products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management. These offerings cater to customers in industry and mining sectors, as well as public sectors such as fire departments, police, and disaster protection. This segment includes stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. The company supports its products with training and services, including fire training facilities for firefighters. With a global presence spanning Europe, the Americas, Africa, Asia, and Australia, Drägerwerk serves a diverse range of customers and industries.
Was das Unternehmen tut
- Develops and manufactures medical devices for acute point of care, including emergency, perioperative, critical, and perinatal care.
- Produces and markets safety technology products for personal protection, gas detection, and hazard management.
- Offers anesthesia devices and ventilators for hospitals and healthcare facilities.
- Provides stationary and mobile gas detection systems for industrial and public sectors.
- Supplies personal protective equipment, including respiratory protection and chemical suits.
- Offers alcohol and drug testing devices for law enforcement and workplace safety.
- Provides training and services, including fire training facilities for firefighters.
- Develops software applications and system products for patient monitoring and data management.
Geschaeftsmodell
- Develops and manufactures medical and safety technology products.
- Markets and sells products directly to hospitals, industrial clients, and public sector organizations.
- Provides after-sales services, maintenance, and training to ensure product performance and customer satisfaction.
- Generates revenue through product sales, service contracts, and training programs.
Branchenkontext
Drägerwerk AG & Co. KGaA operates in the medical devices and safety equipment industry, a sector characterized by continuous innovation and stringent regulatory requirements. The global medical device market is projected to reach trillions of dollars by 2026, driven by an aging population and increasing healthcare spending. The safety equipment market is also growing, fueled by stricter safety regulations and increased awareness of workplace hazards. Drägerwerk competes with companies like AIHLF (Air Liquide), BITGF (Becton Dickinson), BTTAY (Boston Scientific), CMPUY (Medtronic), and CMPVF (Siemens Healthineers), focusing on specialized solutions and integrated systems.
Wichtige Kunden
- Hospitals and healthcare facilities requiring medical devices and patient monitoring systems.
- Industrial companies needing gas detection and personal protective equipment.
- Fire departments, police, and disaster protection agencies requiring safety technology and training.
- Mining companies needing gas detection and respiratory protection equipment.
- Public sector organizations requiring alcohol and drug testing devices.
Finanzdaten
Chart & Info
Drägerwerk AG & Co. KGaA (DGWPF) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer DGWPF verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer DGWPF.
Kursziele
Wall-Street-Kurszielanalyse fuer DGWPF.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von DGWPF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Stefan A. Drager
CEO
Stefan A. Dräger has been a key figure at Drägerwerk, contributing significantly to the company's strategic direction and growth. His leadership is characterized by a focus on innovation, customer-centric solutions, and sustainable business practices. He has been instrumental in driving the company's expansion into new markets and the development of cutting-edge technologies. His deep understanding of the medical and safety technology sectors has enabled Drägerwerk to maintain its competitive edge and adapt to evolving industry trends.
Erfolgsbilanz: Under Stefan A. Dräger's leadership, Drägerwerk has achieved significant milestones, including the successful launch of new product lines and the expansion of its global footprint. He has overseen the implementation of strategic initiatives aimed at improving operational efficiency and enhancing customer satisfaction. His commitment to innovation has resulted in the development of groundbreaking technologies that have strengthened Drägerwerk's market position.
DGWPF OTC-Marktinformationen
The OTC Other tier represents the lowest of the three tiers of OTC Markets. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies are not subject to stringent listing requirements or regulatory oversight. This lack of transparency and regulation increases the risk associated with investing in these companies.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure increases the risk of investing in DGWPF.
- Lower trading volume and wider bid-ask spreads can make it difficult to buy or sell shares.
- Lack of regulatory oversight increases the potential for fraud or mismanagement.
- OTC Other companies may be subject to delisting or trading suspensions.
- Limited analyst coverage and investor interest can result in price volatility.
- Verify the company's registration and regulatory filings.
- Review the company's financial statements, if available.
- Assess the company's business model and competitive landscape.
- Evaluate the company's management team and track record.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Drägerwerk AG & Co. KGaA is a well-established company with a long history in the medical and safety technology markets.
- The company has a global presence and serves a diverse range of customers and industries.
- Drägerwerk has a strong brand reputation for quality and reliability.
- The company's products are subject to regulatory approvals and quality standards.
- Drägerwerk has a management team with experience in the medical and safety technology sectors.
Haeufige Fragen zu DGWPF
What are the key factors to evaluate for DGWPF?
Drägerwerk AG & Co. KGaA (DGWPF) currently holds an AI score of 47/100, indicating low score. Key strength: Strong brand reputation in medical and safety technology.. Primary risk to monitor: Potential: Intense competition from established players in the medical and safety technology markets.. This is not financial advice.
How frequently does DGWPF data refresh on this page?
DGWPF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven DGWPF's recent stock price performance?
Recent price movement in Drägerwerk AG & Co. KGaA (DGWPF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Strong brand reputation in medical and safety technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider DGWPF overvalued or undervalued right now?
Determining whether Drägerwerk AG & Co. KGaA (DGWPF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying DGWPF?
Before investing in Drägerwerk AG & Co. KGaA (DGWPF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding DGWPF to a portfolio?
Potential reasons to consider Drägerwerk AG & Co. KGaA (DGWPF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Strong brand reputation in medical and safety technology.. Additionally: Diversified product portfolio catering to multiple industries.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of DGWPF?
Yes, most major brokerages offer fractional shares of Drägerwerk AG & Co. KGaA (DGWPF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track DGWPF's earnings and financial reports?
Drägerwerk AG & Co. KGaA (DGWPF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for DGWPF earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- OTC data may be less reliable than exchange-listed data.
- AI analysis pending for DGWPF.